Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AMGEN INC
Report date May 09, 2006 · Filed May 11, 2006
Section 16 reporting ended · disclosed 2006-05-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectRevocable Trust | 1,604,988 |
Reported balance
After 2006-05-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2006-05-09 · Gift · Disposed 28,300 · Balance 1,604,988 |
| Common StockSEC Table I · non-derivative | IndirectBy Partnership | 350,000 |
Reported balance
Holding disclosure · report date 2006-05-09 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 350,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 240,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Partnership Disclosed balance after: 843,944 F1 · kind: Note: 1 (FPJ-05/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 15, 2003 Filed May 19, 2003 15:55 UTC | AMGEN INC AMGN · Entity 2832 | OtherCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-008044 · rrd9210.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,154,929 F1 · kind: Note: 1 (FPJ-05/03-Dist.) On May 15, 2003, Asset Management Partners ("AMP") distributed 240,000 shares of Amgen common stock to the partners of the partnership. Accordingly, 80,000 shares were distributed to each of the reporting person and his wife, and 80,000 shares were distributed to the other partners. AMP, of which the reporting person is a general partner, holds 818,944 shares of Amgen common stock. The reporting person disclaims beneficial ownership of the securities held by AMP, and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| May 05, 2003 Filed May 7, 2003 15:59 UTC | AMGEN INC AMGN · Entity 2832 | GiftCommon Stock | 12,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-03-007025 · rrd8426.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,074,929 F1 · balance_after: In addition to the 1,074,929 shares of Amgen Inc. Common Stock directly owned by reporting person following this reported transaction, amount of securities indirectly held include: F2 · balance_after: (a) 1,083,944 shares indirectly held by Asset management Partners for which the reporting person is a general partner. F3 · balance_after: (b) 858,816 shares held by Catherine Johnson, spouse of reporting person. The reporting person disclaims beneficial ownership of the securities indicated and the reporting herein of such securities shall not be construed as an admission that the reporting person is the beneficial owner of any such securities for purposes of Section 16 of the Securities Exchange Act of 1934. F4 · balance_after: (c) 4 units of contractual contingent payment rights held by Asset Management Partners arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.